Search

An interdisciplinary research team at Georgia Tech and the Institut Pasteur has received a 5-year, $2.5 million NIH grant to study phage-immune interactions during treatment of respiratory infections with phages. The team is led by Joshua W

We've already sent out two emergency phage alerts this week! If you can help, we're looking for Acinetobacter baumannii (patient in India) and Pseudomonas aeruginosa (patient in Australia). Please email staff@phage.directory ASAP if you can

We've already sent out two emergency phage alerts this week! If you can help, we're looking for Acinetobacter baumannii (patient in India) and Pseudomonas aeruginosa (patient in Australia). Please email staff@phage.directory ASAP if you can

We are urgently seeking Acinetobacter baumannii phages for a patient in India. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages - By receiving the s

We are urgently seeking Pseudomonas aeruginosa phages for a patient with osteomyelitis in Australia. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phage

We are urgently seeking Pandoraea pulmonicola phages for a cystic fibrosis patient in the USA. Ways to help at this stage: - By receiving the strain and testing your phages - By receiving the strain and using it to search for new phages a

What's the path forward when it comes to phage therapy? According to Shawna McCallin of the University Hospital of Geneva and Phages4All, clinical data is the priority, but it won't be enough. "The recent bankruptcy of Achaogen, a biotech

What's the path forward when it comes to phage therapy? According to Shawna McCallin of the University Hospital of Geneva and Phages4All, clinical data is the priority, but it won't be enough. "The recent bankruptcy of Achaogen, a biotech

Bacteriophage.news is a new platform for phage therapy patients to share their stories.

Bacteriophage.news is a new platform for phage therapy patients to share their stories.

Pherecydes Pharma is joining forces with BIOASTER, a French not-for-profit foundation that brings together academic, industry and its own capacities to execute high-impact, collaborative projects, to explore the use of phage therapy to trea

Thinking of attending Phage Futures EU in Brussels this September? Tomorrow (Friday, July 26) is your last chance for early bird rates! Register here & use PD10 for 10% off!

Armata is seeking a Research Associate I/II to work with the R&D team. The candidate will support the overall program goals and strategy of the group, which include significant laboratory activities such as phage engineering and characteriz

Thinking of attending Phage Futures EU in Brussels this September? Tomorrow (Friday, July 26) is your last chance for early bird rates! Register here & use PD10 for 10% off!

Armata is seeking a Research Associate I/II to work with the R&D team. The candidate will support the overall program goals and strategy of the group, which include significant laboratory activities such as phage engineering and characteriz

Pherecydes Pharma is joining forces with BIOASTER, a French not-for-profit foundation that brings together academic, industry and its own capacities to execute high-impact, collaborative projects, to explore the use of phage therapy to trea

We are urgently seeking Burkholderia cenocepacia phages for a cystic fibrosis patient in the USA. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages -

Harald Brüssow, guest editor of the recently completed "Hurdles for Phage Therapy to Become a Reality" issue of Viruses, has written an editorial on the work (30 papers) published in the issue. His take-home lessons for optimizing phage the

Anca Segall, Dwayne Roach and Steffanie Strathdee recently published a perspective on phage-antibiotic synergy. They conclude that co-treatment with phages and antibiotics has the potential to extend the utility of antibiotics currently in

We are urgently seeking Enterococcus faecium phages for a critically-ill patient in Germany. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages - By h